Search
The Wal-yan Respiratory Research Centre is made up of multi-disciplinary teams that are committed to improving the lives of children and their families living with respiratory disease.
ORIGINS has welcomed its very last baby into the cohort
The AERIAL study, in partnership with The ORIGINS Project, endeavours to understand if exposures during pregnancy and early life can affect the cells lining the airways in newborns, and whether this is associated with the development of wheeze, allergy and asthma later in childhood.
ORIGINS' Dental Screening project has completed its feasibility study, showing that the tested smartphone app, enabling remote screening of children's teeth by dental professionals, has the potential to help remote families access dental care, among other benefits.
Find out how you can get involved with our work at Phage WA.
Here are some of the most common questions about phage, phage therapy and antimicrobial resistance (AMR).
The Wal-yan Respiratory Research Centre is seeking expressions of interest from Western Australians to join an Antimicrobial Resistance (AMR) Community Reference Group, to provide vital community perspectives on the research activities into this global health concern.
Researchers from the Wal-yan Respiratory Research Centre are aiming to combine artificial intelligence with natural, infection-fighting viruses to help save lives from an increasingly common medical emergency found in hospitals.
Patients battling antibiotic-resistant superbugs will soon have access to life-saving WA-made therapies that could help treat lung, skin and ear infections as well as bacterial infections like Golden Staph. Western Australia's inaugural phage manufacturing facility – spearheaded by a team at the
Inklings is a program to support babies aged 6-18 months showing early differences in their social interaction and communication development.